faculty_name,faculty_email,publication_type,title,journal,year,doi,url,file_created
Sergei Muratov,muratos@mcmaster.ca,journal_articles,Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost–effectiveness analysis,Journal of Comparative Effectiveness Research,2024,10.57264/cer-2023-0124,https://experts.mcmaster.ca/display/publication3389387,2025-07-27T15:11:17.334187
Sergei Muratov,muratos@mcmaster.ca,journal_articles,Cost-effectiveness of enzalutamide versus apalutamide versus androgen deprivation therapy alone for the treatment of metastatic castration-sensitive prostate cancer in Canada,Journal of Medical Economics,2022,10.1080/13696998.2022.2066850,https://experts.mcmaster.ca/display/publication2190873,2025-07-27T15:11:17.334191
Sergei Muratov,muratos@mcmaster.ca,journal_articles,Medication use and its impact on high-cost health care users among older adults: protocol for the population-based matched cohort HiCOSTT study,CMAJ open,2021,10.9778/cmajo.20190196,https://experts.mcmaster.ca/display/publication1944402,2025-07-27T15:11:17.334192
Sergei Muratov,muratos@mcmaster.ca,journal_articles,Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators,BMC Cancer,2020,10.1186/s12885-020-07289-z,https://experts.mcmaster.ca/display/publication1923968,2025-07-27T15:11:17.334193
Sergei Muratov,muratos@mcmaster.ca,journal_articles,"Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study",BMJ Open,2019,10.1136/bmjopen-2018-028637,https://experts.mcmaster.ca/display/publication1672926,2025-07-27T15:11:17.334194
Sergei Muratov,muratos@mcmaster.ca,journal_articles,Disease-specific Preference-based Measure of Glaucoma Health States: HUG-5 Psychometric Validation,Journal of Glaucoma,2019,10.1097/ijg.0000000000001267,https://experts.mcmaster.ca/display/publication1642127,2025-07-27T15:11:17.334195
Sergei Muratov,muratos@mcmaster.ca,journal_articles,Unplanned index hospital admissions among new older high-cost health care users in Ontario: a population-based matched cohort study,CMAJ open,2019,10.9778/cmajo.20180185,https://experts.mcmaster.ca/display/publication1662667,2025-07-27T15:11:17.334196
Sergei Muratov,muratos@mcmaster.ca,journal_articles,"Regional variation in healthcare spending and mortality among senior high-cost healthcare users in Ontario, Canada: a retrospective matched cohort study",BMC Geriatrics,2018,10.1186/s12877-018-0952-7,https://experts.mcmaster.ca/display/publication1606880,2025-07-27T15:11:17.334197
Sergei Muratov,muratos@mcmaster.ca,journal_articles,Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma,Journal of Glaucoma,2018,10.1097/ijg.0000000000000984,https://experts.mcmaster.ca/display/publication1527666,2025-07-27T15:11:17.334198
Sergei Muratov,muratos@mcmaster.ca,journal_articles,Managing High‐Cost Healthcare Users: The International Search for Effective Evidence‐Supported Strategies,Journal of The American Geriatrics Society,2018,10.1111/jgs.15257,https://experts.mcmaster.ca/display/publication1497479,2025-07-27T15:11:17.334199
Sergei Muratov,muratos@mcmaster.ca,journal_articles,Senior high-cost healthcare users’ resource utilization and outcomes: a protocol of a retrospective matched cohort study in Canada,BMJ Open,2017,10.1136/bmjopen-2017-018488,https://experts.mcmaster.ca/display/publication1486662,2025-07-27T15:11:17.334200
Sergei Muratov,muratos@mcmaster.ca,journal_articles,SENIOR HIGH COST HEALTHCARE USERS: HOW DO THEY DIFFER?,Innovation in Aging,2017,10.1093/geroni/igx004.222,https://experts.mcmaster.ca/display/publication2716679,2025-07-27T15:11:17.334201
Sergei Muratov,muratos@mcmaster.ca,journal_articles,Loss of health related quality of life following low-trauma fractures in the elderly,BMC Geriatrics,2016,10.1186/s12877-016-0259-5,https://experts.mcmaster.ca/display/publication182496,2025-07-27T15:11:17.334202
Sergei Muratov,muratos@mcmaster.ca,journal_articles,Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis,Clinical and Investigative Medicine,2016,10.25011/cim.v39i2.26481,https://experts.mcmaster.ca/display/publication1443754,2025-07-27T15:11:17.334203
